Novartis Jahresergebnisse 2003

January 22, 2004 01:15 ET | Source: Novartis Pharma AG Novartis Pharma AG

Mit anhaltendem zweistelligem Wachstum bei Umsatz und operativem Ergebnis im Jahr 2003 gehört Novartis zu den Wachstumsstärksten der zehn führenden Pharmaunternehmen*

Please see full press release under the following link:

http://hugin.info/134323/R/931475/127831.pdf

* Laut IMS-Daten Januar - November 2002/3, 17 Länder

Recommended Reading

August 19, 2026 01:15 ET | Source: Novartis Pharma AG

Novartis data at ESC Congress 2026 reinforce cardiovascular leadership and showcase progress in next-generation therapies

Late-breaking Phase IV VICTORION-CHALLENGE data will evaluate Leqvio® (inclisiran) vs. bempedoic acid in achieving LDL-C goalsNew AZALEA-TIMI 71 analyses will further characterize the bleeding profile...
Read More
July 31, 2026 16:25 ET | Source: Novartis Pharma AG

FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease

Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient populationPSMAddition updated results show Pluvicto reduced risk of progression or death by 33% in...
Read More